PRODUCTS
Products
Pharmaceuticals Division – a strong player on the Chinese health care market
The Pharmaceuticals Division focuses on prescription drugs for the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. With its innovative pharmaceutical products, Bayer seeks to achieve a significant therapeutic benefit for patients while at the same time satisfying the growing requirements of physicians and health insurers. The Pharmaceuticals division in China is headquartered in Beijing with facilities in Beijing, Guangzhou, Chengdu and Jiangsu.
Bayer constructed a pharmaceutical production and packaging facility in Beijing from 1995 to 1997, manufacturing solid and semisolid products. To meet the growing needs of the Chinese market, the company invested significantly in the expansion of the company’s Beijing site. The site increased its production capacity several times following the expansion and was equipped with state-of-the-art technology, including the fastest packaging line in both China and the whole Asia-pacific area. In 2011, the Beijing site received the “Good Manufacturing Practice” certification from the Beijing Drug Administration Bureau. It was the first pharmaceutical enterprise in Beijing to receive this certification.
In anticipation of increasing product demand in China, Bayer is investing EUR 100 million to significantly increase the production capacity of its Beijing plant. The planned capacity expansion is designed to ensure a reliable supply of high-quality products to meet the Chinese market’s demand for pharmaceutical products, including the company’s cardiovascular and anti-diabetes products. The expansion will include improved logistics for fully automated material handling, analytical laboratories, and high-speed packaging lines.
The Pharmaceuticals Division’ s Radiology business is a world leader in developing and manufacturing contrast agents used in X-ray, computed tomography (CT) and magnetic resonance imaging (MRI), as well as injection systems for diagnostic and therapeutic medical procedures in CT, MRI and cardiovascular and peripheral vascular diseases.